NM_001003787.4:c.859-978G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001003787.4(STRADA):​c.859-978G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.658 in 155,262 control chromosomes in the GnomAD database, including 35,614 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 35053 hom., cov: 31)
Exomes 𝑓: 0.57 ( 561 hom. )

Consequence

STRADA
NM_001003787.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.28

Publications

31 publications found
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRADANM_001003787.4 linkc.859-978G>A intron_variant Intron 10 of 12 ENST00000336174.12 NP_001003787.1 Q7RTN6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRADAENST00000336174.12 linkc.859-978G>A intron_variant Intron 10 of 12 1 NM_001003787.4 ENSP00000336655.6 Q7RTN6-1
ENSG00000125695ENST00000580553.1 linkn.*773-978G>A intron_variant Intron 9 of 11 5 ENSP00000464100.1 J3QR89

Frequencies

GnomAD3 genomes
AF:
0.660
AC:
100224
AN:
151908
Hom.:
34991
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.906
Gnomad AMI
AF:
0.438
Gnomad AMR
AF:
0.610
Gnomad ASJ
AF:
0.498
Gnomad EAS
AF:
0.581
Gnomad SAS
AF:
0.736
Gnomad FIN
AF:
0.570
Gnomad MID
AF:
0.620
Gnomad NFE
AF:
0.548
Gnomad OTH
AF:
0.623
GnomAD4 exome
AF:
0.572
AC:
1850
AN:
3236
Hom.:
561
Cov.:
0
AF XY:
0.579
AC XY:
1011
AN XY:
1746
show subpopulations
African (AFR)
AF:
0.917
AC:
33
AN:
36
American (AMR)
AF:
0.590
AC:
400
AN:
678
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
4
AN:
14
East Asian (EAS)
AF:
0.583
AC:
49
AN:
84
South Asian (SAS)
AF:
0.692
AC:
173
AN:
250
European-Finnish (FIN)
AF:
0.563
AC:
18
AN:
32
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.545
AC:
1106
AN:
2028
Other (OTH)
AF:
0.588
AC:
67
AN:
114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.660
AC:
100345
AN:
152026
Hom.:
35053
Cov.:
31
AF XY:
0.662
AC XY:
49148
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.906
AC:
37611
AN:
41496
American (AMR)
AF:
0.610
AC:
9320
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.498
AC:
1726
AN:
3466
East Asian (EAS)
AF:
0.582
AC:
3002
AN:
5156
South Asian (SAS)
AF:
0.735
AC:
3543
AN:
4820
European-Finnish (FIN)
AF:
0.570
AC:
6011
AN:
10542
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.548
AC:
37234
AN:
67954
Other (OTH)
AF:
0.622
AC:
1312
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1588
3176
4764
6352
7940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.583
Hom.:
50103
Bravo
AF:
0.670
Asia WGS
AF:
0.683
AC:
2374
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.31
DANN
Benign
0.26
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs721575; hg19: chr17-61782920; COSMIC: COSV107195917; COSMIC: COSV107195917; API